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Background: Sedentary aging leads to adverse changes in vascular function and cardiac performance. We
published improvements in vascular function with moderate intensity physical activity (PA) in continuous
bouts. Whether moderate intensity PA also impacts cardiac structure and cardiovascular performance of the
aging left ventricle (LV) is unknown.
Methods: We recruited and analyzed results from 102 sedentary older adults ages ≥50 from a randomized
controlled trial with 3 study groups: control (group 1), a pedometer-only intervention (group 2), or a pedometer
with an interactive website employing strategies to increase habitual physical activity (PA, group 3) for
12 weeks. Transthoracic echocardiograms were performed prior to and following the 12 week intervention
period to assess cardiacmorphology, left ventricular (LV) systolic performance, LV diastolic function, and arterial
and LV ventricular elastance. Step count and PA intensity/distribution were measured by a pedometer and an
accelerometer.
Results: We found no signiﬁcant changes in cardiac morphology. Further, we found no improvement in the
aforementioned cardiac functional parameters. Comparing those who achieved the following benchmarks to
those who did not showed no signiﬁcant changes in cardiac structure or performance: 1) 10,000 steps/day,
2) ≥30 min/day of moderate intensity physical activity, or 3) moderate intensity PA in bouts ≥10 min for
≥20 min/day
Conclusions: In sedentary older adults, increasing moderate intensity PA to currently recommended levels does
not result in favorable changes in LV morphology or performance over 12 weeks. More prolonged exposure,
higher PA intensity, or earlier initiation of PA may be necessary to see beneﬁts.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Sedentary aging leads to adverse structural adaptations of the heart
and circulatory system. These changes include increased arterial elas-
tance, impaired left ventricular diastolic relaxation and compliance,
and increased left ventricular systolic elastance [1]. While the coupling
relationship of ventricular and arterial compliance is closelymaintained
with matching increases in both physiological attributes, the changes297.
r Medicine, Medical College of
kee, WI 53226, United States.
).
land Ltd. This is an open access articlleave sedentary older adults at greater risk for cardiac ischemia and
heart failure [2,3].
Interestingly, life-long endurance physical activity is associatedwith
signiﬁcant mitigation of age-associated declines in left ventricular
performance and arterial compliance [4]. However, whether increasing
moderate intensity PA (3–6 metabolic equivalents, METs) to currently
promulgated goal levels in older adults can reverse this adverse ventric-
ular and arterial remodeling is unclear. In the context of a 12 week
randomized control trial targeting an activity goal of 10,000 steps/day,
we recently showed that increasing moderate intensity PA can reverse
age-related vascular endothelial dysfunction in previously sedentary
older adults [2]. In the context of this study, we evaluated the effects
of increasing moderate intensity PA on cardiovascular performance
proﬁle in older sedentary adults.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2.1. Subjects
114 sedentary older adults (ages ≥50 and ≤80 years of age) were
recruited for this study based at the Medical College of Wisconsin
(Milwaukee, WI) between 2010 and 2012. The methods and design of
the randomized clinical trial have been previously described in detail
[2]. Brieﬂy, screened participants aged ≥50 years old who averaged
≤8000 steps/day (measured by an Omron HJ-720ITC pedometer
(Omron, Lake Forest, IL)) over 1 week and met all other previously
reported inclusion criteria were randomized. We excluded individuals
with uncontrolled hypertension (≥160/100), recent myocardial infarc-
tion (within 1 month of enrollment), angina, clinical evidence of heart
failure or documented left ventricular ejection fraction of ≤45%, renal
insufﬁciency, liver dysfunction, active malignancy, or cognitive impair-
ment. Only 4 participants reported a prior history of coronary artery
disease, and all had normal ejection fractions without wall motion
abnormalities. The study protocol was approved by theMedical College
of Wisconsin's Institutional Research Board, and all participants
provided written informed consent. Subjects were randomized into 1
of 3 intervention groups: 1) control, 2) pedometer only with verbal
instructions to reach 10,000 steps by increasing step count by 10%/
week and 3) a pedometerwith access to an interactivewebsite designed
to teach ways of integrating moderate intensity physical activity into
daily lifewith the same step count goal as group2 as previously described
[2].
2.2. Study visit procedures (prior to and following the 12 week
intervention period)
2.2.1. General procedures
All subjects fasted overnight prior to their study visit. Height and
weight were measured in metric units. Waist circumference was
measured at the level of the umbilicus while standing. Heart rate and
blood pressure (BP) were measured in triplicate and averaged.
2.2.2. Physical activity procedures
PA was measured and intensity was categorized as previously
described [2]. Brieﬂy, step count and accelerometry data were
collected using Omron HJ-720ITC and ActiGraph GT3X (ActiGraph
GTX3, ActiGraph, Pensacola, FL), for 1 week at the time of enrollment
and during the ﬁnal week of the 12 week intervention period.
For the accelerometer data, time blocks of ≥60 min of continuous
activity count of zero was removed from analysis. This was considered
time when the monitor was not worn. To be considered valid for a
given day, we required the accelerometer to be worn for a minimum
of 600 min/day. Participants with ≥4 days of valid accelerometer data
were included in the analysis. For each minute, the accelerometer data
was coded as sedentary activity (0–100 counts, b1.5 MET intensity),
light activity (101–1951 counts, 1.5–3 METs), moderate intensity
activity (1952–5924 counts, 3–6 METs), or vigorous activity (N5925
counts, N6 METs) [5]. Further, a continuous bout of moderate or
vigorous intensity PA was deﬁned as ≥10 consecutive minutes at the
aforementioned PA intensity.
2.3. Transthoracic echocardiogram
Complete resting transthoracic echocardiograms were performed
following an overnight fast and in resting state by a registered cardiac
sonographer at baseline and 12 weeks. All images were obtained
using a Vivid 7 (General Electric, Milwaukee, WI), with an M3S sector
transducer (1.5–4.6MHz) and obtained by a registered cardiac sonogra-
pher experienced in echocardiographic imaging. All image analyses
were performed off line using standard GE software (EchoPAC). All
quantitative measurements were made in triplicate and averaged forthe ﬁnal reported value. The imageswere obtained from the parasternal,
apical, and subcostal windows by an established protocol. The para-
sternal view provided a full standard view, depth reduced view to eval-
uate the left ventricular (LV) size and wall thickness, and the zoom in
view to evaluate the left ventricular outﬂow tract (LVOT) for measuring
the LVOT diameter. The apical view provided a full standard 2, 3 and 4
chamber view and a depth reduced 2 and 4 chamber view to evaluate
the LVejection fraction (EF) using amodiﬁed Simpson's biplanemethod.
Zoomed 4-chamber apical views were obtained to measure medial and
lateral mitral annular velocities using tissue Doppler imaging. Apical 2,
3, and 4 chamber views were obtained for longitudinal strain imaging
and analysis. Five consecutive ECG gated cardiac cycles were acquired
with a frame rate ≥64 frames per second (fps). Images were stored
digitally and then transferred to an EchoPac (GE Healthcare, Milwaukee,
WI) system for ofﬂine 2D and speckle-tracking analyses. Average strain
rate for each wall segment as well as a global longitudinal strain were
measured. Pulse and continuous wave Doppler images obtained in the
3 and 5 chamber views were obtained for measurements of cardiac
output and the myocardial performance index. All valves underwent
Doppler interrogation to assess for the presence and severity of any
occult valvular disease.
From this set of images, wemeasured arterial elastance (Ea) (0.9 × sys-
tolic blood pressure) / (stroke volume × body surface area) and left
ventricular elastance (Ees), and LV systolic compliance as previously
described [6,7]. Myocardial performance indexwas also calculated as
previously described [8–11].
2.4. Statistical analysis
All analyses were performed using SigmaStat 12.0 and/or SPSS 21.0.
The baseline characteristicswere compared by one-wayANOVAor χ2 as
appropriate. Correlations between step count, cardiovascular perfor-
mance measures, and minutes of PA were calculated using Pearson's r.
Anthropomorphic measurements, measurements of cardiovascular
performance, step count, and time spent in differing levels of PA intensity
were compared using general linear models with time (measurements
pre- and post-12week intervention period) as the within subjects factor
and randomization assignment as the between subjects factor. Group by
time interactions were analyzed for all outcomes. Post hoc testing was
performed using Tukey HSD as appropriate. P values of b0.05 are consid-
ered statistically signiﬁcant. The randomized clinical trial in this study is
powered based on the primary outcomes of changes in endothelial func-
tion by FMD% and arterial stiffness by PWV and the augmentation index
[2]. However, based on prior work with respect to E′ [9,12], our study
with 26 subjects per group has greater than 90% power to detect a
1.5 cm/s increase in E′with our intervention at α= 0.05.
3. Results
3.1. Baseline demographics
As previously reported, a total of 107 of the enrolled 114 subjects
completed the study [2]. The ﬁnal 5 of the 107 subjects did not have
echocardiograms performed due to study ﬁnancial restraints, leaving a
total of 102 subjects available for analyses. There were no signiﬁcant
differences between groups with respect to their sex, age, history of
hypertension, smoking status, and history of diabetes. There were also
no baseline differences in waist circumference, blood pressure, body
mass index, and heart rate (Table 1).
3.2. Changes in baseline demographics by intervention group
Over the 12week study intervention period, weight (P= 0.01), BMI
(P = 0.003), and waist circumference (P = 0.009) decreased for the










Baseline Week 12 Baseline Week 12 Baseline Week 12
Age (years 62 ± 6 – 64 ± 7 – 63 ± 8 – 0.39
Sex (% female) 74.4 – 62.9 – 57.1 – 0.31
History of diabetes (%) 0 – 0 – 3.6 – 0.26
History of hypertension (%) 30.8 – 28.6 – 39.3 – 0.64
Smoking status (% current) 10.3 – 5.7 – 7.1 – 0.77







P-values (time effect/time × group interaction)
Weight (kg) 80.1 ± 16.5 79.4 ± 16.7 83.0 ± 17.4 82.1 ± 17.8 88.0 ± 18.5 86.8 ± 19.2 0.02/0.77
Body mass index (kg/m2) 29.8 ± 6.4 29.1 ± 6.3 28.9 ± 5.0 28.6 ± 5.34 29.8 ± 5.7 29.2 ± 6.1 0.003/0.65
Waist circumference (cm) 99.5 ± 14.0 99.0 ± 14.2 99.5 ± 13.0 98.7 ± 13.1 102.7 ± 14.1 100.8 ± 13.3 0.054/0.02
Systolic blood pressure 130 ± 13 130 ± 16 130 ± 15 127 ± 16 131 ± 14 129 ± 14 0.20/0.54
Diastolic blood pressure 70 ± 9 70 ± 10 68 ± 8 69 ± 8 70 ± 6 70 ± 8 0.67/0.87
Heart rate (bpm) 64 ± 9 65 ± 9 63 ± 9 62 ± 10 63 ± 9 61 ± 8 0.24/0.10
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between study groups, was found (Table 1).
3.3. Changes in step count and physical activity by randomization group
Step count and accelerometer results are reported in Table 2. A total
of 9 subjectswere excluded due to inadequate pedometer or accelerom-
eter measurements based on a priori described quality parameters for
these measures. No signiﬁcant differences in baseline step count
between activity groups at baseline (P = 0.71). Average step count
signiﬁcantly increased in groups 2 and 3 (5136 ± 1554 to 9596 ± 3907
and 5474 ± 1512 to 8167 ± 3111 steps in groups 2 and 3, respectively,
P b 0.001 for the time × group interaction, P b 0.001 within groups
2 and 3) with no change in step count for group 1 (4931 ± 1667 to
5410 ± 2410 steps, P = 0.12). There was no signiﬁcant difference
between the 12 week step counts of groups 2 and 3 (P = 0.16). Overall,
5%, 50%, and 31% of subjects achieved ≥10,000 steps/day by week 12 in
groups 1, 2, and 3, respectively. Combining the 2 intervention groups
(2 and 3), 43% (27/62) of individuals achieved 10,000 steps by week 12.
Detailed accelerometer data has been previously published [2].
Brieﬂy, the accelerometer showed no differences in the total time
observed within groups over the 12 week period (Table 2). Average
daily moderate intensity physical activity (MPA) increased between
weeks 1 and 12 (P b 0.001). MPA at baseline between activity groups
(P = 0.60) showed no differences. There was a signiﬁcant increase in
MPA in groups 2 (19 ± 11 to 48 ± 31 min, P b 0.001) and 3 (19 ± 4
to 35 ± 11, P = 0.001) but not in group 1 (16 ± 10 to 17 ± 14 min,Table 2
Step count and physical activity data by study group.
Control
N = 39 (step counts)
N = 34 (accelerometry)
Pedometer only
N = 35 (step coun
N = 31 (accelerom
Baseline Week 12 Baseline We
Average step count 4841 ± 1665 5142 ± 2143 5168 ± 1568 96
Average minutes observed/day 908 ± 99 889 ± 75 934 ± 112 93
Average moderate intensity activity
minutes (3–6 METs)
16 ± 10 17 ± 14 19 ± 11 49
Average moderate intensity in bouts 4 ± 8 4 ± 8 7 ± 8 14
Subjects achieving ≥10,000 steps 0 0 0 18
Subjects achieving ≥20 min/day
of MPA in bouts
2 3 2 12
Subjects achieving ≥30 min total
of MPA
5 6 4 20P= 0.86). The amount ofMPA between groups 2 and 3 at the conclusion
of the intervention period was not signiﬁcantly different (P = 0.08).
There were no differences in MPA performed in bouts at baseline
(P = 0.38). MPA performed in bouts signiﬁcantly increased within
both group 2 (7 ± 8 to 14 ± 10 min, P b 0.001) and group 3 (7 ± 9 to
27 ± 21 min, P b 0.001), but not group 1 (4 ± 8 to 4 ± 8, P = 0.71).
The time spent in MPA bout activity was signiﬁcantly higher in groups
2 and 3 atweek 12 compared to group 1 (P= 0.01), andwas signiﬁcant-
ly higher in group 3 than group 2 at week 12 (P = 0.005).3.4. Changes in echocardiographic measurements by randomization
cardiovascular and vascular measures by group
Echocardiographic parameters by study group assignment are
reported in Table 3. The echocardiographic measurements showed a sig-
niﬁcant decrease in septalwall thickness for the entire cohort (P= 0.002)
over timewith no differences between groups (P= 0.237). Both LV end-
diastolic volumeand end-systolic volume tended to increase for the entire
population (P = 0.002, P = 0.037) over the 12 week period without
between group differences.
LV ventricular systolic elastance (Ees) did not signiﬁcantly change
over the study period. While both arterial elastance and ventriculo-
vascular coupling (Ea/Ees) and arterial elastance showed signiﬁcant
decreases for the entire study groupover 12 weeks (P= 0.033), neither
parameter signiﬁcantly changed within the study groups. All other
measures of cardiovascular performance and LV systolic and diastolict)
etry)
Pedometer + website
N = 27 (step count)
N = 27 (accelerometry)
P-values
(time effect)
P-values (time × group
interaction)
ek 12 Baseline Week 12
73 ± 3937 5483 ± 1546 8211 ± 3297 b0.001 b0.001
0 ± 121 944 ± 93 944 ± 133 0.48 0.75
± 31 20 ± 14 36 ± 24 b0.001 b0.001
± 10 6 ± 9 27 ± 21 b0.001 b0.001
0 9 – b0.001
2 16 – b0.001
5 15 – 0.001
Table 3
Baseline ventricular–vascular function by study group.





Baseline Week 12 Baseline Week 12 Baseline Week 12
Septal wall thickness (cm) 1.0 ± 0.2 0.9 ± 0.2 0.9 ± 0.2 0.9 ± 0.2 1.0 ± 0.2 1.0 ± 0.3 0.002 0.24
Posterior wall thickness (cm) 1.0 ± 0.1 1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.2 1.1 ± 0.2 1.1 ± 0.2 0.57 0.73
LV end diastolic dimension (cm) 4.3 ± 0.5 4.4 ± 0.5 4.5 ± 0.5 4.5 ± 0.5 4.5 ± 0.5 4.5 ± 0.5 0.08 0.30
LV end systolic dimension (cm) 2.8 ± 0.6 2.9 ± 0.5 3.0 ± 0.6 2.9 ± 0.6 3.0 ± 0.5 3.0 ± 0.5 0.55 0.64
Mean LV end diastolic volume (biplane) 84.6 ± 22.6 91.5 ± 22.1 93.0 ± 21.7 94.7 ± 22.3 91.6 ± 18.7 97.5 ± 21.3 0.002 0.32
Mean LV end systolic volume (biplane) 35.4 ± 12.4 37.8 ± 10.6 37.0 ± 10.1 38.2 ± 10.7 36.9 ± 8.2 39.1 ± 12.0 0.04 0.83
LVEF Simpsons biplane (%) 56.3 ± 7.6 56.3 ± 6.5 57.7 ± 6.3 58.7 ± 6.6 57.2 ± 4.7 57.7 ± 7.7 0.54 0.85
LV outﬂow tract diameter (mm) 1.9 ± 0.2 1.9 ± 0.3 1.9 ± 0.2 2.0 ± 0.3 2.0 ± 0.3 2.0 ± 0.3 0.11 0.68
Mitral E wave velocity (cm/s) 7.2 ± 1.6 7.2 ± 1.5 7.0 ± 2.0 7.1 ± 2.0 7.0 ± 2.0 7.0 ± 1.4 0.74 0.81
Mitral A wave velocity (cm/s) 6.0 ± 2.0 6.2 ± 2.2 5.6 ± 1.8 6.0 ± 1.8 5.8 ± 1.7 5.9 ± 1.9 0.10 0.74
Septal e (cm/s) 6.0 ± 1.5 5.7 ± 1.7 6.1 ± 2.1 6.2 ± 1.7 6.0 ± 1.5 6.0 ± 1.6 0.62 0.69
Lateral e (cm/s) 6.7 ± 1.8 6.8 ± 1.7 7.2 ± 2.1 7.1 ± 2.3 7.0 ± 1.9 6.8 ± 1.8 0.67 0.67
Isovolumetric relaxation time
(IVRT) (ms)
83.4 ± 5.7 83.8 ± 6.4 82.0 ± 5.7 82.5 ± 6.3 83.2 ± 6.1 83.2 ± 5.3 0.68 0.95
Isovolumetric contraction time
(IVCT) (ms)
46.5 ± 7.8 45.0 ± 8.5 44.7 ± 7.8 44.0 ± 6.9 45.6 ± 7.1 44.7 ± 8.1 0.18 0.89
Ejection time ms 309.7 ± 30.4 317.0 ± 26.7 313.6 ± 31.9 320.0 ± 30.5 321.4 ± 24.9 319.3 ± 24.1 0.09 0.20
LV outﬂow tract VTI 21.1 ± 3.7 21.6 ± 3.5 21.4 ± 3.9 21.8 ± 2.9 22.2 ± 3.4 22.1 ± 3.5 0.39 0.69
Aortic VTI 27.5 ± 5.5 29.1 ± 5.5 28.2 ± 6.5 29.1 ± 6.3 28.5 ± 6.6 28.4 ± 6.3 0.05 0.22
Mean stroke volume (SV) (ml/m2) 49.2 ± 12.7 53.7 ± 13.4 56.0 ± 13.8 56.5 ± 13.3 54.7 ± 12.9 58.4 ± 12.8 0.006 0.24
Stroke volume Simpsons (ml/m2) 48.8 ± 12.7 54.5 ± 13.3 55.6 ± 13.7 57.4 ± 12.9 54.4 ± 12.8 58.9 ± 13.3 b0.001 0.31
Stroke volume VTI (ml/m2) 40.1 ± 7.7 41.9 ± 8.0 41.2 ± 8.0 43.8 ± 9.3 43.4 ± 8.3 43.8 ± 10.4 0.044 0.57
LV mass index (g/m2) 79.0 ± 20.7 76.5 ± 25.0 77.9 ± 15.6 76.8 ± 17.0 83.1 ± 22.0 81.8 ± 22.2 0.32 0.93
E/A 1.3 ± 0.4 1.3 ± 0.4 1.3 ± 0.5 1.3 ± 0.4 1.2 ± 0.3 1.3 ± 0.4 0.07 0.11
LV systolic elastance (Ees) 3.3 ± 0.9 3.1 ± 0.7 3.0 ± 0.5 3.0 ± 0.6 3.1 ± 0.8 3.0 ± 0.6 0.47 0.58
Arterial elastance (normalized)
(mm hg/ml)
1.37 ± 0.47 1.22 ± 0.38 1.15 ± 0.37 1.12 ± 0.37 1.13 ± 0.33 1.04 ± 0.29 0.002 0.19
Ea/Ees 0.41 ± 0.08 0.40 ± 0.09 0.38 ± 0.08 0.37 ± 0.08 0.37 ± 0.08 0.36 ± 0.07 0.033 0.55
Mitral annular early diastolic velocity
(average septal/lateral)
6.3 ± 1.5 6.3 ± 1.5 6.7 ± 2.0 6.4 ± 1.8 6.5 ± 1.6 6.4 ± 1.6 0.57 0.93
Ratio of mitral passive inﬂow
velocity and e′ (E/e′)
11.9 ± 3.2 12.2 ± 4.1 11.3 ± 5.0 11.5 ± 4.6 10.9 ± 3.2 11.0 ± 2.6 0.42 0.95
Global longitudinal strain (GLS) −17.0 ± 3.6 −17.5 ± 4.3 −17.8 ± 3.1 −18.1 ± 2.2 −17.3 ± 3.8 −16.1 ± 4.9 0.74 0.12
Myocardial performance index (MPI) 0.30 ± 0.06 0.29 ± 0.07 0.28 ± 0.05 0.28 ± 0.05 0.29 ± 0.05 0.28 ± 0.05 0.65 0.80
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either over time or within study groups.3.5. Changes in echocardiographic parameters and ventriculo-vascular
coupling based on achievement of 1) 10,000 steps/day threshold,
2) ≥20 min/day average of MPA in bouts ≥10 min in length, and
3) 30 min/day MPA average
Data stratifying the study population based on achieving each of the
above activity thresholds are presented in Table 4. Overall, no signiﬁcant
within group changes were seen over time for our measurements of
diastolic function, Ea, Ees, Ea/Ees, or myocardial performance with the
exception of mitral E/A ratio for those achieving 30 min/day of MPA
by the end of the study (P = 0.02 for the interaction of time × group).
This is primarily driven by a decreased E/A ratio in those who did not
achieve 30 min/day of MPM (P = 0.01). There was no change in E/A
ratio for those who did achieve this goal (P = 0.09).3.6. Correlations of age and physical activity with echocardiographic
performance measures
There were no signiﬁcant associations between step count, minutes
of MPA, minutes of MPA in bouts and cardiovascular performance
measures. Age and measures of cardiovascular performance that have
signiﬁcant correlations at baseline were Ees (r = 0.27, P = 0.006), Ea
(r = 0.22, P = 0.03), mitral annular early diastolic velocity (average
septal and lateral) (r = 0.48, P b 0.001), E/e′ (r = 0.32, P = 0.001),
and E/A ratio (r = 0.37, P b 0.001).4. Discussion
In contrast to our prior work showing a favorable impact of increas-
ing MPA on dynamic vascular endothelial function in humans, our cur-
rent data demonstrate that improvement in MPA after a 12 week
intervention in healthy, free-living sedentary adults aged ≥50 does
not signiﬁcantly impact LV systolic performance or diastolic function,
arterial elastance, or ventricular elastance. Our data signiﬁcantly
extends the body of heterogeneous, largely cross-sectional data avail-
able comparing the LV performance, LV compliance, and arterial elas-
tance of younger individuals to older sedentary individuals and older
life-long trained athletes by demonstrating that commonly advocated
public health recommendations to improve physical activity by achiev-
ing 10,000 steps/day [13,14] or 30minMPA/day [15] are not associated
with near-term improvement in LV systolic performance or LV diastolic
function [4,16–20]. Combined with prior data, our study suggests that
reversing sedentary aging-related LV remodeling and increased arterial
elastance requires either 1) a more prolonged exposure to MPA or a
greater intensity of PA or 2) earlier intervention to reverse the impact
of sedentary aging. Further, these data suggest that the favorable cardio-
vascular impact of MPA in older adults may relate in larger portion to
improvements in dynamic vascular endothelial function as opposed to
LV reverse remodeling.
Aging is known to impact the structure and function of the cardio-
vascular system, and age-related remodeling appears to be secondary
to both alterations in cardiac myocyte phenotype as well as increased
collagen deposition within an aging myocardium [21].
LV early diastolic ﬁlling rates progressively decrease after age 20 and
by 80 years old are reduced by up to 50% [21]. Impaired LV diastolic
function occurring with age often manifests echocardiographically
Table 4
Cardiovascular performance based on physical activity regimen.
Bout b 20 min (N = 62) Bout ≥ 20 min (N = 30) P-values
(time effect)
P-values
(time × group interaction)
Baseline Week 12 Baseline Week 12
LV systolic elastance (Ees) 3.2 ± 0.8 3.0 ± 0.7 3.0 ± 0.6 3.0 ± 0.6 0.28 0.17
Ea over Ees 0.39 ± 0.08 0.38 ± 0.09 0.38 ± 0.08 0.37 ± 0.06 0.10 0.72
Arterial elastance (normalized) (mm Hg/ml) 1.25 ± 0.42 1.15 ± 0.39 1.14 ± 0.37 1.11 ± 0.30 0.03 0.27
Mitral annular early diastolic velocity (average septal/lateral)a 6.3 ± 1.5 6.3 ± 1.5 6.7 ± 2.0 6.4 ± 1.8 0.57 0.93
E/A 1.3 ± 0.5 1.2 ± 0.4 1.3 ± 0.3 1.4 ± 0.4 0.91 0.018
Ratio of mitral passive inﬂow velocity and E′b 11.5 ± 3.3 11.7 ± 4.0 10.7 ± 4.9 10.9 ± 3.7 0.41 0.93
Myocardial performance index 0.29 ± 0.06 0.29 ± 0.06 0.28 ± 05 0.28 ± 0.05 0.88 0.82
10,000 b steps (N = 75) 10,000 ≥ 20 steps (N = 27)
LV systolic elastance 3.1 ± 0.7 3.0 ± 0.6 3.1 ± 0.8 3.0 ± 0.7 0.22 0.53
Ea over Ees 0.39 ± 0.08 0.38 ± 0.08 0.38 ± 0.08 0.37 ± 0.07 0.05 0.55
Arterial elastance (normalized) 1.25 ± 0.42 1.15 ± 0.36 1.17 ± 0.40 1.12 ± 0.35 0.02 0.37
Mitral annular early diastolic velocity (average septal/lateral)c 6.5 ± 1.7 6.4 ± 1.6 6.5 ± 1.9 6.5 ± 1.8 0.71 0.81
E/A 1.3 ± 0.4 1.3 ± 0.4 1.2 ± 0.4 1.2 ± 0.4 0.62 0.62
Ratio of mitral passive inﬂow velocity and E′d 11.3 ± 3.2 11.5 ± 3.7 12.0 ± 5.5 12.0 ± 4.8 0.55 0.75
Myocardial performance index 0.29 ± 0.06 0.29 ± 0.06 0.29 ± 0.05 0.28 ± 0.05 0.70 0.95
MPA b 30 min (N = 51) MPA ≥ 30 min (N = 40)
LV systolic elastance 3.2 ± 0.8 3.0 ± 0.7 2.9 ± 0.6 3.0 ± 0.6 0.14 0.09
Ea over Ees 0.39 ± 0.09 0.39 ± 0.09 0.38 ± 0.07 0.37 ± 0.06 0.10 0.60
Arterial elastance (normalized) 1.28 ± 0.44 1.18 ± 0.40 1.12 ± 0.34 1.08 ± 0.30 0.01 0.25
Mitral annular early diastolic velocity (average septal/lateral)e 6.4 ± 1.7 6.3 ± 1.7 6.6 ± 1.8 6.7 ± 1.7 0.78 0.52
E/A 1.4 ± 0.5 1.2 ± 0.4 1.2 ± 0.3 1.3 ± 0.4 0.65 0.003
Ratio of mitral passive inﬂow velocity and E′f 11.6 ± 3.5 11.9 ± 4.2 10.9 ± 4.3 10.9 ± 3.6 0.40 0.54
Myocardial performance index 0.29 ± 0.06 0.29 ± 0.07 0.29 ± 0.05 0.29 ± 0.05 0.83 0.77
Bold values indicate signiﬁcance at P b 0.05.
a N = 61 and 30, respectively
b N = 61 and 29, respectively
c N = 74 and 27, respectively
d N = 74 and 26, respectively
e N = 50 and 41, respectively
f N = 50 and 40, respectively
23T.B. Suboc et al. / IJC Heart & Vessels 4 (2014) 19–24with reduced early diastolic relaxation velocity of themitral annulus (e′),
reduced mitral passive to active diastolic inﬂow velocities (E/A ratio) in
the absence of increased left atrial pressure, and prolonged isovolumetric
relaxation time (IVRT) in the absence of increased left atrial pressure [10,
22]. Consistent with this prior literature, our study population shows
impaired e′ velocities' velocity (E′) [9,10]. Further, the correlations
between diastolic parameters, Ea, Ees and increasing age in our study
population are entirely consistent with sedentary aging-related changes
in these parameters.
However, while LV compliance is favorably impacted by exercise
training in young adults [23], the impact of exercise training and phys-
ical activity on age-related deterioration of LV compliance remains
unclear. Cross-sectional data suggest that echocardiographic parame-
ters of LV diastolic relaxation and compliance, including mitral E/A
ratio, IVRT, and LV inﬂow propagation velocity, are not fully preserved
by lifelong exercise training, while mitral annular tissue velocities
could be favorably impacted [12,17,20]. Invasivemeasurements suggest
that LV compliance is favorably preserved in lifelong trained individuals
compared to age-matched controls [4]. Differences between these
studies may relate to differences in study populations, the heterogene-
ity of the durations and compositions of training programs of individ-
uals enrolled, and differences in measure of LV diastolic performance.
One non-randomized study of nine older adults employing a year-long
vigorous aerobic training program failed to demonstrate a signiﬁcant
impact on age-related impairment of LV compliance [16]. Our study
extends these data by showing, in the setting of a randomized study,
that increasing physical activity in previously sedentary older adults to
currently promulgated goal PA levels does not reverse aging related
LV changes, suggesting several potential possibilities: 1) improvements
in this population may require greater PA intensity and/or a greater
duration of training, and 2) LV remodeling in sedentary older adults
may have limited reversibility secondary to age-related LV remodelinginvolving potentially more immutable alterations in interstitial struc-
ture [16,24]. Further interventional studies are necessary in this area
to better determine whether PA of any type, duration, and intensity
can reverse age-related deterioration of LV compliance.
While arterial elastance (Ea) increases with age and is associated
with increased cardiovascular risk [3], limited data are available on the
impact of exercise training on Ea. In the previously cited small interven-
tional study, Ea was favorably reduced by 1 year of vigorous exercise
training [16]. Our data show no signiﬁcant impact of moderate intensity
PA at currently recommended levels of activity of Ea over a shorter inter-
vention period. Taken together, these data suggest that either a longer
duration of moderate intensity PA is required to reduce age-related
increases in arterial elastance or vigorous intensities are required.
Further interventional studies will be needed to better determine the
amount and intensity of PA needed for these favorable effects.
Combining prior ﬁndings with our current work, available evidence
suggests that the cardiovascular beneﬁts of physical activity in older
adults are derived in larger part due to improvements in dynamic vascu-
lar regulation and structure rather than alterations of left ventricular
performance. This concept is buoyed by ﬁndings by our laboratory and
others that exercise training in previously sedentary older adults
improves vascular endothelial function and reduces vascular stiffness
while, as reviewed above, the majority of data regarding the impact of
exercise training in previously sedentary older adults on LV speciﬁc
measures have been underwhelming [2,16,25]. The lack of impact of
MPA in the current study on measures of arterial stiffness suggests
that MPA at the level and dose achieved was insufﬁcient to reverse
age-related vascular remodeling rather than negating prior encouraging
ﬁndings.
Our study has some limitations. The use of non-invasivemeasures of
early diastolic ﬁlling aided the feasibility of this trial, but invasive mea-
sures of diastolic function such as rate of LVpressure decline or LVﬁlling
24 T.B. Suboc et al. / IJC Heart & Vessels 4 (2014) 19–24pressures may have allowed greater sensitivity to the impact of PA on
LV performance. A more prolonged exposure to PA may have greater
impact on both arterial and vascular remodeling. Our study population
included no subjects with active ischemic heart disease or LV systolic
dysfunction. Our results cannot be generalized to those with active
ischemic disease or LV systolic dysfunction. Balanced against these
limitations are the interventional nature of our data and its focus on
the impact of currently promulgated PA duration and intensity on
arterial and ventricular elastance.
In conclusion, our data suggest that increasing moderate intensity
physical activity to currently recommended levels over 12 weeks does
not signiﬁcantly impact LV or arterial compliance in previously seden-
tary older adults. Combinedwith prior cross-sectional and limited inter-
ventional data, our data suggest that the favorable cardiovascular
impact of habitual physical activity in older adults who have recently
begun an activity regimen may be related in larger portion to improve-
ments in dynamic vascular function rather than reverse remodeling of
the left ventricle. Further interventional work is necessary to better
determine the dosing of physical activity that maximizes its cardio-
vascular beneﬁts in older adults.
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